Is Cisco As Cheap As It Looks?

Cisco Systems, Inc. (NASDAQ:CSCO)’s fiscal year ended in July, with the company reporting strong numbers for the fourth fiscal quarter that brought its revenue 7% higher for the year than in the last fiscal year and earnings up by 24%. Many of the company’s costs were held flat or even declined, most notably sales and marketing expenses. Cisco’s ongoing heavy buyback program (the 10-K reported that $4.8 billion in cash was used to repurchase common stock), helped pull earnings per share up even further, at a 27% rate. While we wouldn’t suggest that the large networking and communication devices company will see this growth rate in the current fiscal year, it probably shouldn’t see a sharp decline either and modest growth is probably the base case scenario.

Ken Fisher FISHER ASSET MANAGEMENT

Yet Cisco Systems, Inc. trades at fairly low earnings multiples: 12 times trailing earnings and 9 times estimates for the current fiscal year (and keep in mind that extended buybacks will likely augment higher net income). This is because despite the better bottom line the stock is actually down 4% from a year earlier, while the broader market indices have seen returns of 10% or higher. Cisco also pays a good dividend (it increased its payment recently) and therefore has a yield of 3.2% to return additional cash to shareholders. The stock therefore looks cheap as long as it can deliver small growth rates in its business going forward.

Billionaire Ken Fisher’s Fisher Asset Management made a large purchase of Cisco shares in the second quarter of the year, and owned 21 million shares at the end of June (see more of billionaire Ken Fisher’s stock picks). First Eagle Investment Management also liked the stock: that fund also bought shares during the second quarter, and its 13F filing listed Cisco Systems, Inc. as the largest position by market value in First Eagle’s portfolio with a total of 46 million shares (research other stocks that First Eagle liked). Sandy Nairn’s Edinburgh Partners cut its stake by 12% but still reported owning 14 million shares of the company;p this made it one of the top picks in Edinburgh’s portfolio as well (find other top picks from Edinburgh Partners).

To construct a peer group for Cisco, we’d look at Alcatel Lucent SA (NYSE:ALU), Juniper Networks, Inc. (NYSE:JNPR), Palo Alto Networks Inc (NYSE:PANW), and Riverbed Technology, Inc. (NASDAQ:RVBD). On a forward basis, Cisco is by far the cheapest of these comparable companies. The two which are priced the closest are Riverbed and Juniper, which both carry forward P/Es of 16. Juniper had a bad third quarter: its revenue was up slightly compared to the third quarter of 2011, but its earnings plummeted. With its forward P/E actually depending quite a bit on expected growth, we’d avoid it. Riverbed is more appealing, as it grew both its top and bottom lines at double-digit rates last quarter versus a year earlier. Its valuation anticipated quite a bit of continued growth, so we’d still consider Cisco to be the better value.

Alcatel-Lucent has had its stock price cut in half over the last year, and still trades at 20 times consensus estimates for its 2013 earnings. This is because its revenue has been down, and it is struggling with profitability (earnings were negative in each of the first two quarters of 2012). We don’t think it’s reached the point yet where it would be a good value. Palo Alto seems to be the fastest-growing of these companies; in its most recent quarter sales were nearly double what they were a year earlier. It is probably good to keep an eye on such a rapidly growing company, but the stock price is a bit high for us for now as it is only seeing 3-4 cents per share in earnings per quarter.

We think that investors should take a look at Cisco. Its pricing is fairly cheap (including relative to its peers), the company has a commitment to returning cash to shareholders, and growth looks to be at least modest in the near future.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!